T

hese are uncertain times for the National Institutes of Health, which is facing serious threats to its funding. That’s led to questions about the future of  NIH’s big projects, such as the Precision Medicine Initiative.

The Obama-era initiative aims to recruit 1 million volunteers with diverse backgrounds, and probe their genetic and health data. The hope is to gain new insight into how disease manifests — and how best to treat it.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.

X